United states

Marvell Technology and Bausch Health are being bought

Bausch Health: “We wanted to buy today, but we ran out of time. This thing is going on sale. There are shorts that lower it completely. This is quite ridiculous. I wanted to be able to buy a huge bit of it today, so I feel for it [Charitable Trust]”

Accenture: “They crushed these stocks. The business is fantastic. They had a great quarter. I tell people [buy, buy, buy]”

Celularity: “This is one of the riskiest stocks out there. The way I would look at it is, be prepared to lose everything, but otherwise you will earn a lot of money if you succeed.

Manulife: “They take too much risk, Manulife. I’m not there for 5% [dividend yield]. I do not need. Too much risk in ordinary stocks. “

Marvell Technology: “I have to [keep buying more of it]. This company has two businesses: high-performance computing and 5G. We know that these are the two strongest areas. There is no computer business. No games. Marvell is a stock that we buy, buy, buy for the charity, and I think you should too. “

Iron Mountain: “I like Iron Mountain. Good yield, very consistent business. [Buy, buy, buy]”

Disclosure: Cramer’s Charitable Trust owns shares in BHC and MRVL.

Sign up for the CNBC Investing Club now to follow every move by Jim Cramer in the market.